Shin'ichiro Fujii

フジイシンイチロウ | Shin'ichiro Fujii

Affiliation and department：
Job title：チームリーダー
Papers (62)：

Tomonori Iyoda, Satoru Yamasaki, Michihiro Hidaka, Fumio Kawano, Yu Abe, Kenshi Suzuki, Norimitsu Kadowaki, Kanako Shimizu, Shin-ichiro Fujii. Amelioration of NK cell function driven by Vα24+ invariant NKT cell activation in multiple myeloma. Clinical Immunology. 2018. 187. 76-84
Tomonori Iyoda, Satoru Yamasaki, Michihiro Hidaka, Fumio Kawano, Yu Abe, Kenshi Suzuki, Norimitsu Kadowaki, Kanako Shimizu, Shin-ichiro Fujii. Restoration of NK cell function against multiple myeloma cells by an adjunctive effect of activated invariant natural killer T (NKT) cells. CYTOKINE. 2017. 100. 128-129
Dennis C. Harrer, Bianca Simon, Shin-ichiro Fujii, Kanako Shimizu, Ugur Uslu, Gerold Schuler, Kerstin F. Gerer, Stefanie Hoyer, Jan Dorrie, Niels Schaft. RNA-transfection of gamma/delta T cells with a chimeric antigen receptor or an alpha/beta T-cell receptor: a safer alternative to genetically engineered alpha/beta T cells for the immunotherapy of melanoma. BMC CANCER. 2017. 17. 1. 551
Shin-ichiro Fujii, Kanako Shimizu. Exploiting antitumor immunotherapeutic novel strategies by deciphering the cross talk between invariant NKT cells and dendritic cells. Frontiers in Immunology. 2017. 8. 886
Daisuke Yamada, Tomonori Iyoda, Raul Vizcardo, Kanako Shimizu, Yusuke Sato, Takaho A. Endo, Genta Kitahara, Momoko Okoshi, Midori Kobayashi, Maki Sakurai, et al. Efficient Regeneration of Human V alpha 24(+) Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo. STEM CELLS. 2016. 34. 12. 2852-2860

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page